AstraZeneca chief defends China business as staff are arrested in Beijing corruption crackdown
Astrazeneca chief executive Pascal Soriot (pictured) said the company was taking the arrests of eight or nine employees 'very seriously'.
AstraZeneca
Manufacturing · United Kingdom · 89,900 Employees
View Company Info for Free
About
Headquarters
Biomedical Campus 1 Francis Crick Cambridge Ave...Phone Number
+44 2037495000Website
www.astrazeneca.comRevenue
$49.1 BillionStock Symbol
AZNIndustry
Most Recent Scoops
Sep 9 2024
Hiring Plans
Sep 3 2024
Open Position
Highlights
$1.2B
Total Funding Amount
$168M
Most Recent Funding Amount
2
Number of Funding Rounds
Who is AstraZeneca
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Ca rdiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca was founded in 1999 and is based in the United Kingdom.Read more
AstraZeneca Org Chart
Is AstraZeneca your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AstraZeneca, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AstraZeneca recently announced quarterly report
Check if AstraZeneca has recently received funding, and reach out quickly before it becomes old news!
Check out if AstraZeneca is spiking on competitors!
Funding: Get notified immidiatlly once AstraZeneca has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AstraZeneca had a recent Job posting/layoffs
Product Launch: Get notified when AstraZeneca launches new products
Congratulate Masked Content for being promoted to Masked Content at AstraZeneca
Recommended Actions
Find VP level buyers at AstraZeneca
Find 2 more new buyers
Similar Companies to AstraZeneca
Analyze insights from companies similar to AstraZeneca and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- GSK70,212
$40B - CSL32,065$14.2B
- Pfizer88,000$54.9B
- Merck & Co70,000$61.4B
- Novartis76,057$47.7B
- Bristol-Myers Squibb34,100$45.5B
- Takeda47,347$26.9B
- AbbVie50,000$54.4B
More similar companies
Compare CEO
How does Pascal Soriot compare against Competing Companies' CEOs?
Pascal Soriot
CEO at AstraZeneca
Top 30%
CEO management styleGood
100%Bad
0%VS.
Severin Schwan
CEO at Roche
Top 5%
CEO effectiveness to drive business results
Excellent
60%
Good
20%
Average
0%
Poor
20%
Very Bad
0%
Good
85%Bad
14%Severin Schwan
CEO at Roche
Giovanni Caforio
CEO at Bristol-Myers Squibb
Chris Christophe...
CEO at Bayer
AstraZeneca Email Formats
AstraZeneca uses at least 5 email formats with first.last (ex. John.Smith@astrazeneca.com) being used 76.4% of the time
| AstraZeneca Email Formats | Percentage | |
|---|---|---|
| first.last | John.Smith@astrazeneca.com | 76.4% |
| first initials + last | JSmith@astrazeneca.de | 5.5% |
| first_last | John_Smith@astrazeneca.de | 1.3% |
| first + last | JohnSmith@astrazeneca.com | |
| first | John@astrazeneca.com | |
Get Verified Emails
View Email Formats for AstraZeneca
AstraZeneca financials insights
Gather financial insights about AstraZeneca, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
AstraZeneca Employee Growth Rate
View AstraZeneca’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
AstraZeneca Tech Stack
A closer look at the technologies used by AstraZeneca
Top Companies in United Kingdom
Top 10 companies in United Kingdom by revenue
Top 10 companies in United Kingdom by number of employees
Top 10 companies in United Kingdom by total funding amount
Most Recent Scoops
Sep 9 2024
Hiring Plans
Sep 9 2024
Hiring Plans
Sep 3 2024
Open Position
Sep 3 2024
Open Position
Sep 2 2024
Open Position
AstraZeneca News & Media
Pillar Biosciences Partners with AstraZeneca to Help Accelerate Access to Liquid Biopsy Testing
Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions. NATICK, Mass., Sept. 10, 2024 /PRNewswire/ -- Pillar Biosciences, Inc. has entered into a strategic partnership...AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector. The investigation focuses on potential breaches of data privacy laws and the importation of unlicensed cancer medications. CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention. The probe centers around AstraZeneca’s eAstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
Monday, AstraZeneca Plc (NASDAQ:AZN) shared detailed results from the TROPION-Lung01 Phase 3 of datopotamab deruxtecan (Dato-DXd) compared to docetaxel, the current standard of care chemotherapy for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with at least one prior line of therapy. Detailed results showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab deruxtecan (Dato-DXd) compared to docetaxel. Also Read: AstraZenDatopotamab deruxtecan showed median overall survival of 14.6 months in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
WILMINGTON, Del.--(BUSINESS WIRE)--Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab deruxtecan (Dato-DXd) compared to docetaxel, the current standard of care chemotherapy, in adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with at least one prior line of therapy. These results will be presented today during an oral presentation (OA08.03)
Read more news
Frequently Asked Questions Regarding AstraZeneca
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca was founded in 1999 and is based in the United Kingdom.... Read More
